These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8603484)

  • 1. Inhibitory effects of 1-O-hexyl-2,3,5-trimethylhydroquinone (HTHQ), green tea catechins and other antioxidants on 2-amino-6-methyldipyrido[1,2-a:3',2'-d]imidazole (Glu-P-1)-induced rat hepatocarcinogenesis and dose-dependent inhibition by HTHQ of lesion induction by Glu-P-1 or 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx).
    Hirose M; Hasegawa R; Kimura J; Akagi K; Yoshida Y; Tanaka H; Miki T; Satoh T; Wakabayashi K; Ito N
    Carcinogenesis; 1995 Dec; 16(12):3049-55. PubMed ID: 8603484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention by antioxidants of heterocyclic amine-induced carcinogenesis in a rat medium-term liver bioassay: results of extended and combination treatment experiments.
    Hirose M; Futakuchi M; Tanaka H; Orita SI; Ito T; Miki T; Shirai T
    Eur J Cancer Prev; 1998 Feb; 7(1):61-7. PubMed ID: 9511852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenolics: blocking agents for heterocyclic amine-induced carcinogenesis.
    Hirose M; Takahashi S; Ogawa K; Futakuchi M; Shirai T
    Food Chem Toxicol; 1999; 37(9-10):985-92. PubMed ID: 10541455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strong inhibition of 2-amino-6-methyldipyrido[1,2-a:3',2'-d] imidazole-induced mutagenesis and hepatocarcinogenesis by 1-O-hexyl-2,3,5-trimethylhydroquinone.
    Hirose M; Akagi K; Hasegawa R; Satoh T; Nihro Y; Miki T; Sugimura T; Ito N
    Jpn J Cancer Res; 1993 May; 84(5):481-4. PubMed ID: 8320163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strong anti-mutagenic activity of the novel lipophilic antioxidant 1-O-hexyl-2,3,5-trimethylhydroquinone against heterocyclic amine-induced mutagenesis in the Ames assay and its effect on metabolic activation of 2-amino-6-methyldipyrido[1,2-a:3',2'-d] imidazole (Glu-p-1).
    Hirose M; Iwata S; Ito E; Nihro Y; Takahashi S; Mizoguchi Y; Miki T; Satoh T; Ito N; Shirai T
    Carcinogenesis; 1995 Sep; 16(9):2227-32. PubMed ID: 7554080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemoprevention of heterocyclic amine-induced carcinogenesis by phenolic compounds in rats.
    Hirose M; Takahashi S; Ogawa K; Futakuchi M; Shirai T; Shibutani M; Uneyama C; Toyoda K; Iwata H
    Cancer Lett; 1999 Sep; 143(2):173-8. PubMed ID: 10503899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention by synthetic phenolic antioxidants of 2-amino-3, 8-dimethylimidazo[4,5-f]quinoxaline (MeIQx)- or activated MeIQx-induced mutagenesis and MeIQx-induced rat hepatocarcinogenesis, and role of antioxidant activity in the prevention of carcinogenesis.
    Hirose M; Ito T; Takahashi S; Ozaki M; Ogiso T; Nihro Y; Miki T; Shirai T
    Eur J Cancer Prev; 1998 Jun; 7(3):233-41. PubMed ID: 9696932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoprevention of 2-amino-1-methyl-6-phenylimidazo[4,5-b]-pyridine (PhIP)-induced mammary gland carcinogenesis by antioxidants in F344 female rats.
    Hirose M; Akagi K; Hasegawa R; Yaono M; Satoh T; Hara Y; Wakabayashi K; Ito N
    Carcinogenesis; 1995 Feb; 16(2):217-21. PubMed ID: 7859351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of DMBA-initiated rat mammary tumour development by 1-O-hexyl-2,3,5-trimethylhydroquinone, phenylethyl isothiocyanate, and novel synthetic ascorbic acid derivatives.
    Futakuchi M; Hirose M; Miki T; Tanaka H; Ozaki M; Shirai T
    Eur J Cancer Prev; 1998 Apr; 7(2):153-9. PubMed ID: 9818778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modifying effects of chitin, chitosan and their related compounds on 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) in a rat medium-term hepatocarcinogenesis model, and their post-initiation effects in a female rat 2-stage multi-organ carcinogenesis model.
    Kawabe M; Futakuchi M; Tamano S; Shirai T; Hirose M
    Food Chem Toxicol; 2008 Aug; 46(8):2758-63. PubMed ID: 18547703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stage and organ dependent effects of 1-O-hexyl-2,3,5-trimethylhydroquinone, ascorbic acid derivatives, n-heptadecane-8-10-dione and phenylethyl isothiocyanate in a rat multiorgan carcinogenesis model.
    Ogawa K; Futakuchi M; Hirose M; Boonyaphiphat P; Mizoguchi Y; Miki T; Shirai T
    Int J Cancer; 1998 Jun; 76(6):851-6. PubMed ID: 9626352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemoprevention of heterocyclic amine-induced mammary carcinogenesis in rats.
    Hirose M; Nishikawa A; Shibutani M; Imai T; Shirai T
    Environ Mol Mutagen; 2002; 39(2-3):271-8. PubMed ID: 11921198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx)-induced CYP1A2 expression is associated with bovine lactoferrin inhibition of MeIQx-induced liver and colon carcinogenesis in rats.
    Fujita K; Ohnishi T; Sekine K; Iigo M; Tsuda H
    Jpn J Cancer Res; 2002 Jun; 93(6):616-25. PubMed ID: 12079509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effects of tea catechins, black tea extract and oolong tea extract on hepatocarcinogenesis in rat.
    Matsumoto N; Kohri T; Okushio K; Hara Y
    Jpn J Cancer Res; 1996 Oct; 87(10):1034-8. PubMed ID: 8957060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of GST-P positive liver cell foci development by combined treatment of rats with five heterocyclic amines at low doses.
    Ito N; Hasegawa R; Shirai T; Fukushima S; Hakoi K; Takaba K; Iwasaki S; Wakabayashi K; Nagao M; Sugimura T
    Carcinogenesis; 1991 May; 12(5):767-72. PubMed ID: 2029739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemoprevention of 2-amino-1-methyl-6-phenylimidazo- [4,5-b]pyridine-induced colon carcinogenesis by 1-O-hexyl-2,3,5-trimethylhydroquinone after initiation with 1,2-dimethylhydrazine in F344 rats.
    Futakuchi M; Hirose M; Imaida K; Takahashi S; Ogawa K; Asamoto M; Miki T; Shirai T
    Carcinogenesis; 2002 Feb; 23(2):283-7. PubMed ID: 11872633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic enhancement of hepatic foci development by combined treatment of rats with 10 heterocyclic amines at low doses.
    Hasegawa R; Miyata E; Futakuchi M; Hagiwara A; Nagao M; Sugimura T; Ito N
    Carcinogenesis; 1994 May; 15(5):1037-41. PubMed ID: 8200065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose dependence of 1-O-hexyl-2,3,5-trimethylhydroquinone promotion of forestomach carcinogenesis in rats pretreated with N-ethylnitrosourethane.
    Mizoguchi Y; Hirose M; Yamaguchi T; Boonyaphiphat P; Miki T; Shirai T
    Jpn J Cancer Res; 1998 May; 89(5):475-80. PubMed ID: 9685849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of antioxidant 1-O-hexyl-2,3,5-trimethylhydroquinone or ascorbic acid on carcinogenesis induced by administration of aminopyrine and sodium nitrite in a rat multi-organ carcinogenesis model.
    Yada H; Hirose M; Tamano S; Kawabe M; Sano M; Takahashi S; Futakuchi M; Miki T; Shirai T
    Jpn J Cancer Res; 2002 Dec; 93(12):1299-307. PubMed ID: 12495469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic alterations in HCA-induced tumors.
    Ushijima T; Makino H; Kakiuchi H; Inoue R; Sugimura T; Nagao M
    Princess Takamatsu Symp; 1995; 23():281-91. PubMed ID: 8844820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.